We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Stenprop Limited | LSE:STP | London | Ordinary Share | GG00BFWMR296 | ORD EUR0.000001258 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 181.75 | 180.00 | 183.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSTP
RNS Number : 6200S
Stenprop Limited
12 March 2019
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALINGS IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR OF THE COMPANY AND BY A DIRECTOR OF MAJOR SUBSIDIARIES OF THE COMPANY
12 March 2019
Shareholders are advised of the following information relating to dealings in securities by an associate of a director of the Company and by a director of major subsidiaries of the Company:
Name of associate: Millicent Limited Name of director and relationship Patsy Watson, who is a discretionary to director: beneficiary of the Swallow Trust which has a beneficial interest in Millicent Limited Transaction date: 11 March 2019 Class of securities: Ordinary shares Number of securities: 116,500 Price per security: GBP 1.1325 Total value: GBP 131,936.25 Nature of transaction: On-market sale on the London Stock Exchange ("LSE") Nature and extent of director's Indirect beneficial interest: ----------------------------------- ---------------------------------------- Name of director of major subsidiaries: Neil Marais Name of major subsidiaries: Stenprop (UK) Limited and Stenprop (Germany) Limited Transaction date: 11 March 2019 Class of securities: Ordinary shares Number of securities: 8,045 Price per security: GBP 1.1325 Total Value: GBP 9,110.96 Nature of transaction: On-market sale on the LSE Nature and extent of director's Direct beneficial interest: Yes Clearance to deal received: ---------------------------------------- ----------------------------------
For further information:
Stenprop Limited Paul Arenson Patsy Watson Julian Carey +44(0)20 3918 6600 Numis Securities Limited (Financial Adviser) Hugh Jonathan Vicki Paine +44(0)20 7260 1000 JSE Sponsor Java Capital Trustees and Sponsors Proprietary Limited + 27 (0) 11 722 3050
About Stenprop
Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHCKBDQDBKDCND
(END) Dow Jones Newswires
March 12, 2019 09:00 ET (13:00 GMT)
1 Year Stenprop Chart |
1 Month Stenprop Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions